MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation EV 2011-2026 | DHR
EV Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145 B | 150 B | 177 B | 175 B | 193 B | 148 B | 133 B | 95.2 B | 90.3 B | 76.8 B | 69.5 B | 54.4 B | 48.8 B | 43.7 B | 39.3 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 193 B | 39.3 B | 109 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
45.8 B | $ 119.97 | 0.82 % | $ 36.5 B |  USA |
 |
Anixa Biosciences
ANIX
|
990 K | $ 2.96 | 4.59 % | $ 96.1 K | USA |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 22.65 | -3.78 % | $ 237 M |  China |
 |
Celcuity
CELC
|
506 M | $ 110.91 | 3.27 % | $ 4.38 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
665 M | $ 28.34 | 2.79 % | $ 787 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 179.2 | 1.92 % | $ 8.88 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 14.0 | 1.53 % | $ 423 M | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K |  Israel |
|
Biodesix
BDSX
|
142 M | $ 14.83 | -4.32 % | $ 1.92 B | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
IDEXX Laboratories
IDXX
|
52.7 B | $ 650.18 | 2.3 % | $ 52.3 B | USA |
 |
Illumina
ILMN
|
15.3 B | $ 129.26 | -0.23 % | $ 20.6 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.15 | 2.68 % | $ 1.46 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 208.68 | 0.16 % | $ 23.2 B | USA |
 |
Organovo Holdings
ONVO
|
-4.05 M | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | $ 103.52 | 0.15 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
904 M | $ 8.57 | -2.0 % | $ 537 M | USA |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 9.51 | -7.67 % | $ 270 M | Israel |
 |
DexCom
DXCM
|
28.2 B | $ 73.23 | 0.21 % | $ 28.6 B | USA |
 |
PerkinElmer
PKI
|
4 B | - | -0.91 % | $ 14.7 B | USA |
 |
Psychemedics Corporation
PMD
|
20.5 M | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B |  Niderland |
 |
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 110.76 | 1.89 % | $ 9.14 B |  Irlanda |
 |
Renalytix AI plc
RNLX
|
33.9 M | - | 5.66 % | $ 22.7 M | Britain |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 19.25 | 2.37 % | $ 1.03 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 281.56 | -0.53 % | $ 23.4 B | USA |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 77.63 | -1.53 % | $ 5.24 B | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | Israel |
 |
Guardant Health
GH
|
15.2 B | $ 93.91 | 0.65 % | $ 11.8 B | USA |
 |
IQVIA Holdings
IQV
|
49.6 B | $ 176.67 | 1.53 % | $ 30.4 B | USA |
 |
Brainsway Ltd.
BWAY
|
223 M | $ 12.53 | 8.07 % | $ 99.4 M | Israel |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 299.09 | -1.29 % | $ 26.8 B | Schweiz |
 |
Co-Diagnostics
CODX
|
29.3 M | - | - | $ 79.8 M | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 5.36 | 1.23 % | $ 496 M | USA |